SCHEMBL3133584

SCHEMBL3133584

Cc1c(C(=O)NN)sc2ccc(Cl)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGG1 O15527 2/20 0.52
MAPT P10636 4/20 0.52
GAA P10253 5/20 0.49
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 2/20 0.49
F10 P00742 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 2/20 0.46
MEN1 O00255 1/20 0.46
GFER P55789 1/20 0.46
KMT2A Q03164 1/20 0.46
CXCR2 P25025 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
CMA1 P23946 2/20 0.44
PFKFB3 Q16875 1/20 0.44
PFKFB4 Q16877 1/20 0.44
ROCK1 Q13464 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6360877 0.83 L3MBTL1 (0.51) MAPTGAAALDH1A1KDM4ELMNA
SCHEMBL122587 0.81 GPR35 (0.58) MAPTF10L3MBTL1NPSR1CMA1
SCHEMBL121696 0.81 MAPT (0.50) MAPTALDH1A1KDM4EF10L3MBTL1
SCHEMBL121489 0.81 MAPT (0.50) MAPTKDM4EF10L3MBTL1CXCR2
SCHEMBL5845473 0.81 MAPT (0.50) MAPTALDH1A1F10L3MBTL1RAB9A
SCHEMBL3318210 0.79 MAPT (0.49) MAPTALDH1A1F10L3MBTL1MEN1
SCHEMBL6958000 0.78 MAPT (0.48) MAPTF10L3MBTL1CXCR2NPSR1
SCHEMBL6659125 0.78 MAPT (0.49) MAPTALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL3142929 0.77 F10 (0.44) MAPTGAAALDH1A1F10L3MBTL1
SCHEMBL4921770 0.77 PFKFB3 (0.43) MAPTGAAALDH1A1LMNAF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004221-A1 THIAZEPINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-01-07 US disclosed
EP-2119719-A1 THIAZEPINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004221-A1 THIAZEPINE DERIVATIVE HSD11B1, HSD17B1, HSD3B1 OGG1 2861/4885MAPT 4734/4885GAA 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.